Suppr超能文献

2019 新型冠状病毒肺炎患儿外周血淋巴细胞亚群及血清细胞因子特征。

The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia.

机构信息

Department of Hematology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei, China.

Department of Clinical Pharmacology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology, 100 Hong Kong road, Jiang'an District, Wuhan, Hubei 430016, China.

出版信息

J Infect. 2020 Jul;81(1):115-120. doi: 10.1016/j.jinf.2020.04.001. Epub 2020 Apr 20.

Abstract

OBJECTIVES

The study was aimed at investigating the characteristics of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus (2019-nCoV) pneumonia.

METHODS

Children with 2019-nCoV pneumonia or with respiratory syncytial virus (RSV) pneumonia were included. Data including lymphocyte subsets and serum cytokines were collected and analyzed.

RESULTS

56 patients were included in the study, 40 children with 2019-nCoV pneumonia and 16 children with RSV pneumonia. Compared with children with RSV pneumonia, patients with 2019-nCoV pneumonia had higher count of CD3+8+ lymphocyte, higher percentages of CD3+, CD3+8+ lymphocytes and a lower percentage of CD19+ lymphocyte. The serum IL-10 level was significantly higher in children with RSV pneumonia. One 2019-nCoV pneumonia child who was with an obvious increase of IL-10 developed severe pneumonia.

CONCLUSIONS

Immune response played a very important role in the development of 2019-nCoV pneumonia. The effective CD8+ T cell response might influence the severity of 2019-nCoV pneumonia. The adaptable change in IL-10 level might contribute to the relatively mild pneumonia symptoms in children with 2019-nCoV pneumonia and bacterial co-infection might be a risk factor of severe 2019-nCoV pneumonia.

摘要

目的

本研究旨在探讨 2019 年新型冠状病毒(2019-nCoV)肺炎患儿外周血淋巴细胞亚群和血清细胞因子的特征。

方法

纳入 2019-nCoV 肺炎或呼吸道合胞病毒(RSV)肺炎患儿,收集并分析淋巴细胞亚群和血清细胞因子等数据。

结果

本研究共纳入 56 例患儿,其中 2019-nCoV 肺炎患儿 40 例,RSV 肺炎患儿 16 例。与 RSV 肺炎患儿相比,2019-nCoV 肺炎患儿 CD3+8+淋巴细胞计数较高,CD3+、CD3+8+淋巴细胞比例较高,CD19+淋巴细胞比例较低。RSV 肺炎患儿血清 IL-10 水平明显升高。1 例 2019-nCoV 肺炎患儿 IL-10 明显升高,发展为重症肺炎。

结论

免疫反应在 2019-nCoV 肺炎的发生发展中起重要作用。有效的 CD8+T 细胞反应可能影响 2019-nCoV 肺炎的严重程度。IL-10 水平的适应性变化可能有助于解释儿童 2019-nCoV 肺炎和细菌合并感染症状相对较轻,而细菌合并感染可能是 2019-nCoV 肺炎重症的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/107b/7169899/41da255ecce5/gr1_lrg.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验